Prediction of prostate cancer in extended-field biopsies of the prostate

OBJECTIVES To assess the prediction of prostate cancer using extended-field prostatic biopsies (8–11 cores), as such biopsy protocols are recommended to increase the detection of prostate cancer, and as fewer cancers are missed this should improve the prediction of biopsy outcome from the patients’ history, transrectal ultrasonography (TRUS) and serum markers. PATIENTS AND METHODS In all, 260 patients were prospectively evaluated and 206 with a total prostate-specific antigen (PSA) level of